On May 12, 2025, President Trump signed an executive order to align U.S. prescription drug prices with lower costs in Europe and the UK, a move aimed at reducing healthcare expenses for Americans. The order, detailed on WhiteHouse.gov, received minimal mainstream media coverage, suggesting its significance as a consumer-friendly policy. Trump also nominated Casey Means as Surgeon General, sparking online controversy. Laura Loomer, a vocal commentator, launched aggressive attacks on Means and her brother Calley, a top RFK Jr. adviser, alleging ethical issues. A wellness CEO filed an ethics complaint against Calley, which Loomer amplified, though critics call it baseless and a publicity stunt leaked to Politico to fuel the news cycle. The feud highlights tensions within conservative circles over Trump’s appointees. The executive order’s lack of coverage underscores its potential impact, as networks often downplay policies that challenge pharmaceutical interests. Means’ nomination and the drug pricing reform signal Trump’s focus on healthcare affordability, despite distractions from online disputes and unverified complaints. For details, visit WhiteHouse.gov for the full list of Trump’s executive orders.
- Yesterday President Trump signed an executive order concerning prescription drugs and what it will do to change the prices. Trump has named Casey Means to be the Surgeon General. There is a battle online between Laura Loomer and Casey Means.
- Wellness CEO files ethics complaint against top RFK Jr adviser. Laura Loomer is going full-throated-attack on Calley and Casey Means. It is a fake complaint and leaking it to Politico is not devastating to feed the news cycle.
- You can read the full list of executive orders on the WhiteHouse.gov
- You know that it is a positive move and a good move when no one covers it. None of the networks covered this. The executive order would align drug prices in the US with those sold in Europe and the UK.